文献速递浆细胞疾病

靶向长链非编码RNA NEAT1损害DNA修复机制并在多发性骨髓瘤中触发抗肿瘤活性

Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma.
PubMed 文献 · Leukemia · 2019-08-19

该研究探讨长链非编码RNA NEAT1在多发性骨髓瘤中的功能意义,发现NEAT1在MM中表达高于多数血液恶性肿瘤;用LNA-gapmeR反义寡核苷酸沉默NEAT1可在体外和鼠MM模型中抑制细胞增殖并触发凋亡;NEAT1靶向下调DNA修复(含同源重组)基因导致大量DNA损伤,并与PARP抑制剂及硼替佐米、卡非佐米、美法仑协同促凋亡。

要点

  • NEAT1在MM中表达高于多数血液恶性肿瘤
  • 沉默NEAT1抑制MM增殖并触发凋亡(体外及鼠模型)
  • NEAT1靶向下调DNA修复基因并与PARP抑制剂及MM常用药协同

核心结论

  • NEAT1沉默在MM中具有抗肿瘤活性,并与常规及新型治疗产生化疗增敏效应,靶向NEAT1可能成为新的抗MM治疗策略。

研究设计与样本

  • 研究使用LNA-gapmeR反义寡核苷酸沉默NEAT1,在体外MM细胞和鼠MM模型中评估其功能。
  • 通过转录组分析探讨NEAT1靶向后的基因表达变化。

主要发现

  • NEAT1表达水平在MM中高于大多数血液恶性肿瘤。
  • NEAT1沉默抑制MM细胞增殖并在体外和鼠MM模型中触发凋亡。
  • NEAT1靶向下调参与DNA修复(包括同源重组通路)的基因,导致大量DNA损伤。
  • NEAT1与PARP抑制剂共处理MM细胞系可协同诱导凋亡。
  • NEAT1靶向与硼替佐米、卡非佐米和美法仑具有协同效应。

临床怎么用

  • NEAT1靶向可能作为MM的潜在治疗策略,并与PARP抑制剂及常用化疗药物联合增敏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The biological role and therapeutic potential of long non-coding RNAs (lncRNAs) in multiple myeloma (MM) are still open questions. Herein, we investigated the functional significance of the oncogenic lncRNA nuclear paraspeckle assembly transcript 1 (NEAT1) in MM. Our study demonstrates that NEAT1 expression level is higher in MM than in the majority of hematological malignancies. NEAT1 silencing by novel LNA-gapmeR antisense oligonucleotide inhibits MM cell proliferation and triggers apoptosis in vitro and in vivo murine MM model as well. By transcriptome analyses, we found that NEAT1 targeting downregulates genes involved in DNA repair processes including the Homologous Recombination pathway, which in turn results in massive DNA damage. These findings may explain the synergistic impact on apoptosis observed in MM cell lines co-treated with inhibitors of both NEAT1 and PARP. The translational significance of NEAT1 targeting is further underlined by its synergistic effects with the most common drugs administered for MM treatment, including bortezomib, carfilzomib, and melphalan. Overall, NEAT1 silencing is associated with a chemo-sensitizing effect of both conventional and novel therapies, and its targeting could therefore represent a promising strategy for novel anti-MM therapeutic options.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Taiana E, Favasuli V, Ronchetti D, et al. Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma. Leukemia. 2019. PMID: 31427718. doi:10.1038/s41375-019-0542-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。